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d Instituto Universitario de Investigación Marina (INMAR), Campus Rio San Pedro, 11510, Puerto Real, Cádiz, Spain   







A B S T R A C T   
The knowledge about the effects of pharmaceuticals on aquatic organisms has been increasing in the last decade. 
However, due to the variety of compounds presents in the aquatic medium, exposure scenarios and exposed 
organisms, there are still many gaps in the knowledge on how mixtures of such bioactive compounds affect 
exposed non target organisms. The crayfish Procambarus clarkii was used to analyze the toxicity effects of mix-
tures of ciprofloxacin, flumequine and ibuprofen at low and high concentrations (10 and 100 μg/L) over 21 days 
of exposure and to assess the recovery capacity of the organism after a depuration phase following exposure 
during additional 7 days in clean water. The crayfish accumulated the three compounds throughout the entire 
exposure in the hepatopancreas. The exposure to the mixture altered the abundance of proteins associated with 
different cells functions such as biotransformation and detoxification processes (i.e. catalase and glutathione 
transferase), carbohydrate metabolism and immune responses. Additionally changes in expression of genes 
encoding antioxidant enzymes and in activity of the corresponding enzymes (i.e. superoxide dismutase, gluta-
thione peroxidase and glutathione transferase) were reported. Alterations at different levels of biological orga-
nization did not run in parallel under all circumstances and can be related to changes in the redox status of the 
target tissue. No differences were observed between control and exposed organisms for most of selected end-
points after a week of depuration, indicating that exposure to the drug mixture did not produce permanent 
damage in the hepatopancreas of P. clarkii.   
1. Introduction 
A large variety of pharmaceuticals (275 to date, Mezzelani et al., 
2018) are present worldwide in the aqueous environment, including 
influents and effluents of wastewater treatment plants WWTPs, surface 
(rivers, lakes and coastal waters), ground and drinking waters. Medi-
cations from human and veterinary use can enter the aquatic environ-
ment through different routes but effluents from sewage treatment 
plants (STPs) are generally recognised as the main source of these 
substances (Daughton and Ternes, 1999; Fent et al., 2006; Heberer, 
2002; Yang et al., 2017). After consumption/application drugs reach, 
largely in unaltered form, the STPs where conventional processes are not 
effective in their removal or degradation. Therefore, a large number of 
pharmaceuticals are present in effluents from STPs and may reach 
different aquatic compartments (Behera et al., 2011; Castiglioni et al., 
2006; Nakada et al., 2006; Paxéus, 2004; Santos et al., 2007). The 
continuous release from multiple pathways combined with the low 
degradation rate in the aqueous medium due to their chemical 
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uco.es (R. Fernández-Cisnal), miriam.hampel@uca.es (M. Hampel), rutft@us.es (R. Fernández-Torres), mabello@us.es (M.Á. Bello-López), bb1abdim@uco.es 
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properties makes pharmaceuticals “pseudo-persistent” contaminants 
(Bu et al., 2016; Ebele et al., 2017; Richman and Castensson, 2008). 
Consequently, aquatic organisms are continually exposed to a complex 
mixtures of pharmaceuticals and, although levels of these compounds in 
the aquatic environments are generally very low ranging from ng/L to 
low μg/L, pharmaceuticals are highly reactive molecules designed to 
interact with biological systems even at low concentrations and hence 
sub-lethal, long-term effects can be expected (Bu et al., 2013; Desbiolles 
et al., 2018; Petrie et al., 2015; Ying et al., 2013). Due to the potential 
hazard of these compounds, research into pharmaceutical pollution has 
extensively expanded in the last decade (Kay et al., 2017). Even so, most 
works have focused on the global analysis of drugs in the aquatic 
environment (detection and quantification in different aquatic com-
partments, sources, removal efficiency in STPs, risk assessment, etc.) 
and toxic effects of pharmaceuticals as single compounds. Studies 
focusing on the effects of pharmaceutical mixtures on aquatic organisms 
are thus necessary, particularly under chronic exposure conditions 
(David et al., 2020; Hossain et al., 2021). 
This work centres on three pharmaceuticals commonly detected in 
the freshwater aquatic compartment. Ibuprofen (IBU), one of the most 
used non-steroidal anti-inflammatory drugs (NSAID), is commonly 
detected in surface waters with concentrations ranging from <0.3 ng/L 
to 16 μg/L (Valcarcel et al., 2011; Ying et al., 2013; Ziylan and Ince, 
2011). This compound has been detected in different fish and inverte-
brate tissues and has shown to induce sublethal adverse effects 
(behavioural changes, immunological and haematological alterations, 
modulation of enzyme activities and gene expression, endocrine 
disruption, genotoxic effects, etc.) both in fresh and saltwater organisms 
(Gonzalez-Rey and Bebianno, 2011; Maranho et al., 2014; Mathias et al., 
2018; Mezzelani et al., 2018; Miller et al., 2018; Parolini et al., 2011; 
Serrano et al., 2015; Xia et al., 2017). Ciprofloxacin (CIP) and flume-
quine (FLU) belong to the broad-spectrum antibiotics fluoroquinolones, 
a class of special environmental concern due to their extensive use and 
the high resistance to abiotic and biotic degradation (Ebert et al., 2011; 
Robinson et al., 2005a). Liu et al. (2018) include CIP among the most 
frequent antibiotics detected in aquatic environments; concentrations of 
this compound ranging from ng/L to μg/L (0.1–9660 ng/L) have been 
reported in different water resources worldwide (Carvalho and Santos, 
2016; Bradley et al., 2017) and acute and chronic toxicity (particularly 
at concentrations > mg/L) was studied in a variety of aquatic groups 
particularly algae, plants and bacteria revealing the induction of dele-
terious effects (mortality, growth and reproduction inhibition, photo-
synthesis efficiency decrease, etc.) in exposed organisms (Ebert et al., 
2011; Gomes et al. 2017, 2018, 2018; Halling-Sorensen et al., 2000; 
Martins et al., 2012). Nevertheless very few works have been conducted 
to study the CIP effects on more complex aquatic organisms (in-
vertebrates and vertebrates) and, even less, at environmentally relevant 
concentrations and focusing on molecular and submolecular endpoints 
(Gust et al. 2012, 2013, 2013; Halling-Sorensen et al., 2000; Martins 
et al., 2012; Maul et al., 2006). Data available for FLU, the second 
antimicrobial selected in this study, are even scarcer than for CIP and 
only limited to its detection in aquatic environments (10–41 ng/L, 
Carvalho and Santos, 2016) and its acute toxic effects on a few species of 
algae, bacteria and crustaceans (Brian et al., 2007; Migliore et al., 1997; 
Robinson et al., 2005). 
Crustaceans have been widely used in ecotoxicological research 
(Lyubenova and Boteva, 2016). The crayfish Procambarus clarkii (Girard, 
1852), native of the southern United States, was introduced worldwide 
assuming an important role in the trophic chain of colonized systems 
and, nowadays is one of the most common crayfish species cultured 
commercially for human consumption (Gonçalves Loureiro et al., 2015; 
Liu et al., 2011; Moss et al., 2010; Sheir et al., 2015). Due to the high 
knowledge of its biological characteristics and its ecologic and economic 
importance, P. clarkii has been widely used as a model species for the 
assessment of contaminant effects in field and are considered as a good 
model organism to study changes induced by pollutants (Osuna-Jiménez 
et al., 2014; Serrano et al., 2000; Suárez-Serrano et al., 2010; Vio-
que-Fernández et al., 2009a; Yu et al., 2018). The use of a species as a 
bioindicator needs preliminary studies to characterize and understand 
the responses to environmental stressors, and this knowledge is critical 
for interpreting changes in biological responses and using them as an 
early warning signal of pollutant detection. Information about the 
adverse effects of pharmaceuticals on P. clarkii is very scarce. This study 
focused on the mixture of selected compounds (a more environmentally 
realistic exposure scenario, since in aquatic systems organisms are 
simultaneously exposed to many chemicals) and we tested the hypoth-
esis that, at environmentally relevant dose, it is able to induce sub-lethal 
responses (particularly responses related with oxidative stress/damage 
or with depuration processes) in target tissues of P. clarkii. Based on the 
idea that contaminants interact at different biological organization 
levels (molecular, cellular, tissue, etc.) and that alterations can be 
related to each other (cascade of events from molecular to higher or-
ganization levels for example) (Ankley et al., 2010) we choose a 
multivariate approach integrating the study of conventional toxicolog-
ical biomarkers, expression of selected genes and the massive analysis of 
effects at the proteomic level. We also suppose that different factors can 
modulate all this responses between them chemical dosage, exposure 
duration (short, medium or long-term) and intermittent exposure 
(exposure and depuration phases). 
Animals were exposed to the drug mixture for 21 days at two sub-
lethal doses, the first one (10 μg/L) closest to environmentally relevant 
concentrations and other ten fold higher (100 μg/L), similar to levels 
detectable in highly contaminated areas or receiving waters from some 
specific locales such as hospitals, pharmaceutical factories, farms, etc. 
(Chopra and Kumar 2020; Carvalho and Santos, 2016) and supposedly 
capable of inducing distinguishable responses in the organisms, to 
determine the effects of the mixture in the hepatopancreas, the main 
organ involved in nutrient storage and a variety of immune responses 
and detoxification processes (Gibson, 1979). Biochemical parameters 
(oxidative stress, neurotoxicity and detoxification biomarkers), gene 
transcription and protein expression were evaluated at different times 
(after 1, 7 and 21 days) to assess their evolution in the short and medium 
term and try to understand the possible toxicity mechanisms of the 
mixture. Additionally, pre-exposed organisms were depurated in clean 
freshwater for 7 days and bioaccumulation, biochemical biomarkers and 
gene expression were evaluated in the P. clarkii hepatopancreas with the 
aim of investigating the recovery capability of the organisms (if the 
possible toxic effects are permanent or reversible) after removal of 
pharmaceuticals from the exposure medium. 
2. Materials and methods 
2.1. Animals, experimental procedure and sampling 
Specimens of P. clarkii were collected at the lagoon of “La Janda” 
(36◦13′05.6′′N, 5◦47′02.3′′W, Cádiz, Spain). Before the beginning of the 
experiment, crayfish were acclimated in aerated, dechlorinated fresh-
water to laboratory conditions forat least1 week. Exposure was carried 
out for 21 days in tanks with aerated and dechlorinated freshwater (1L/ 
animal) under natural photoperiods. Plastic tubes were placed in the 
tanks to avoid cannibalism. Pharmaceuticals, obtained from Sigma 
Aldrich (Steinheim, Germany, purity≥98%, main characteristics shown 
in Supplementary material, Table S1), were added to the exposure tanks 
as a stock solution prepared in dimethyl sulfoxide (final DMSO con-
centration in the tanks: 0.002% v/v) to reach the final nominal con-
centration of 10 and 100 μg/L (concentration of each compound present 
in the mixture) and every condition, DMSO control (control), mixture at 
10 μg/Land mixture at 100 μg/L, was tested in triplicate. Water was 
completely changed and chemical renewed every 48 h and organisms 
were fed with extruded sinking fish feed pellets (Skretting, Nutreco 
Company, Spain) 3 h before the water change. 
Biological sampling was carried out at the start of the experiment 
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(day 0, from the acclimatization tank) and after 1, 7 and 21 days. Every 
sampling day, organisms were chosen randomly (14 animals per tank) 
and the hepatopancreas was excised, frozen in liquid nitrogen and stored 
at − 80 ◦C until further analyses. Tanks were cleaned and the remaining 
animals were maintained for 7 additionally days to assess their possible 
recovery in depuration conditions. Water change and feeding intervals 
were performed as during the exposure phase. 
Water sampling was regularly performed to quantify pharmaceutical 
concentrations and ammonium content in the tanks. 
Temperature, pH, conductivity and dissolved oxygen were recorded 
routinely in the exposure medium (17.8±1.6 ◦C, 8.3±0.2, 477.4±30.5 
μS/cm and 8.5±0.8 mg/L respectively) both during exposure and dep-
uration phases and crayfish mortality daily checked (2.5% average 
mortality). 
2.2. Chemical analysis 
Hepatopancreas samples (15 organisms per condition: 5 individual 
hepatopancreas × 3 tanks) were individually lyophilized (Labconco 
Freezone 2.3, MA, USA) and then extracted by applying microwave 
energy (5 min, 50 W power, Ethos 900, Milestone)). Lyophilized sample 
(0.1 g) was treated with 2 mL of a mixture acetonitrile (ACN): water 1:1 
(v/v) spiked with 10 μL proteinase-K PCR recombinant of 20.2 mg/mL 
(Roche Diagnosis, Barcelona, Spain) and 1 μL of formic acid. The ob-
tained extracts were then centrifuged (Hettich Universal 320) for 10 min 
at 9000 rpm, and evaporated under nitrogen stream until nearly dry-
ness. Finally, the extract was reconstituted with 100 μL of 0.1% formic 
acid aqueous solution and microfiltrated through 0.2 μm before LC-ESI- 
QTOF-MS (XEVO G2-S Waters Corporation, Mildford, MA, USA) 
injection. 
Water samples were microfiltered (0.2 μm) and a 10 μL aliquot was 
directly injected into LC-ESI-QTOF-MS system. 
The chromatographic separation was performed on an Acquity UPLC 
BEH C18 column (50 mm × 2.1 mm, 1.7 μm, Waters Corporation, Mil-
ford, MA, USA). The mobile phase was water (A) and ACN (0.1% formic 
acid) (B). A gradient elution program was applied for 10 min consisting 
in 90% A initially to a 45% A in 4.5 min, a subsequent isocratic step for 
3.5 min returning to initial conditions at t= 8.0 min. 2 min were waited 
for reequilibration before the following injection. The flow rate was set 
at 0.3 mL/min. Detection was carried out at Xevo G2S QTOF mass 
spectrometer, in full scan resolution mode and ESI positive/negative 
mode was applied for ionization of the analytes.CIP, FLU and IBU 
analytical standards (from Sigma-Aldrich, Merck Life Science S.L.U., 
Spain) were used for standard curves. Instrumental limits of quantifi-
cation (LOQs) resulting for the method were in the range of 3.12–4.19 
ng/g for biological sample analysis (CIP: 3.21, FLU: 4.19, IBU: 3.12) and 
1.92–2.73 ng/L for water sample analysis (CIP: 1.92, FLU: 2.73, IBU: 
2.12). Instrumental limits of detection (LODs) were in the range of 
0.99–1.99 ng/g (CIP: 0.99, FLU: 1.65, IBU: 1.99) and 0.16–0.94 ng/L 
(CIP: 0.16, FLU: 0.89, IBU: 0.94) respectively for biological sample and 
water samples analysis. 
Ammonium levels in water samples were quantified according to the 
method of Krom (1980) and varied from 1.0 to 9.3 μmol/L. 
2.3. Biochemical analysis 
Hepatopancreas samples (6 organisms per condition: 2 pooled 
hepatopancreas x 3 tanks) were homogenized (weight: volume ratio of 
1:4) with 50 mM Tris buffer (150 mM NaCl, 1 mM dithiothreitol (DTT), 
0.1% antiproteolitic cocktail) pH 7.4 using an Ultra-turrax homogenizer 
(ULTRA-TURRAX T25, Janke&Kunkel, IKA®Labortechnich). The ho-
mogenate was then centrifuged at 12000×g at 4 ◦C during 30 min to 
obtain a supernatant (S12 fraction) and aliquots were collected for 
biochemical analysis. 
2.3.1. Total protein, enzyme activity analysis and lipid peroxidation 
All biochemical determinations were performed in triplicate by 
spectrophotometry (microplate reader Tecane Infinite 200, Tecane 
Group Ltd, Austria). 
Total protein content was determined according to Bradford’s 
method (Bradford, 1976) using bovine serum albumin (BSA) as standard 
and was used for normalization of data for biomarkers. 
Catalase (CAT) activity was evaluated measuring the absorbance 
decrease (230 nm) due to the hydrogen peroxide consumption during 5 
min (30 s intervals) according to the method described by Beers and 
Sizer (1952) and modified by Li and Schellhorn (2007). CAT activity was 
expressed as U CAT/mg proteins where one unit of enzyme (U) is 
defined as the amount of enzyme that caused the loss of 1.0 μmol of 
H2O2 per min, under the assay conditions. 
Superoxide dismutase (SOD) activity was assessed using a SOD Assay Kit- 
WST (Dojindo Laboratories, Japan) according to the method of Ukeda et al. 
(1999) based on the reaction of water-soluble tetrazolium salt (2-(4-io 
dophenyl)-3-(4—nitrophenyl)-5-(2,4-disulfo-phenyl)-2H-tetrazolium, mon-
osodium salt, WST-1). SOD from bovine erythrocytes was used as standard. 
Results were expressed as U SOD/mg proteins where unit of SOD (U) is 
defined as the amount of the enzyme in the sample volume that inhibits the 
reduction reaction of WST-1 with the superoxide anion by 50%. 
Glutathione reductase (GR) determination was conducted following 
the method of Cohen and Duvel (1988) modified for microplate reader 
by McFarland (1999). The loss of NADPH present in the reaction mixture 
was recorded at 340 nm over 10 min (1 min intervals) and activity was 
reported as nmol NADPH consumed/min/mg proteins. 
Glutathione-S-transferase (GST) activity was determined following 
the method described by McFarland (1999) using 1-chloro-4,4-dinitro-
benzene as a substrate. Absorbance was recorded at 340 nm during 3 
min (30 s intervals) and activity was reported as μmol CDNB/min/mg 
proteins. 
Total glutathione transferase (T-GPx) assay was conducted using 
cumene hydroperoxide as substrate (McFarland, 1999) and the loss of 
NADPH present in the reaction mixture was monitored as the reaction 
progress (absorbance at 340 nm during 3 min, 10 s intervals). Activity 
was expressed as nmol NADPH/min/mg proteins. 
Lipid peroxidation (LPO) levels were quantified following the thio-
barbituric acid reactive substances (TBARS) method as described by 
Hannam et al. (2010). Oxidative stress leads to malondialdehyde (MDA) 
production as final product of oxidative lipid degradation (Janero, 
1990). The 1,1,3,3-tertramethoxypropane produced in the reaction be-
tween MDA and trichloroacetic acid can be quantified spectrophoto-
metrically (535 nm) as indirect measure of MDA. Results were expressed 
as nmol MDA/mg proteins. 
Acetylcholinesterase (AChE) activity was determined using the 
method described by Matozzo et al. (2012) in which reaction progress 
between S-acetylthiocholine iodide (ACTC) and dithiobisnitrobenzoate 
is followed by recording absorbance (405 nm) changes during 5 min (30 
s intervals). Activity was expressed as μmol ACTC/min/mg proteins. 
2.3.2. Metallothionein 
Total metallothionein (MT) content was determined in the super-
natant by reverse phase high performance liquid chromatography (RP- 
HPLC) coupled to fluorescence detection (W2695 Separation Module, 
2475 Multi λ fluorescence Detector, WATERS Corporation, Milford, MA, 
USA) using rabbit liver MT-I as a reference for standard curve, according 
to the protocol developed by Alhama et al. (2006, 2011) and Romer-
o-Ruiz et al. (2008). Supernatant was derivatized with the fluorogenic 
reagent monobromobimane (mBBr) after treatment at 70 ◦C with eth-
ylenediaminetetraacetic acid (EDTA), sodium dodecyl sulphate (SDS) 
and DTT. Final concentrations for DTT, EDTA, SDS and mBBr in a total 
volume of 100 μL were 10 mM, 2 mM, 3% and 12 mM respectively. 
Derivatized proteins were separated in a C18 X Bridge column (6 × 150 
mm, 5 μm particle, WATERS Corporation, Milford, MA, USA) and 
fluorescence was monitored with excitation at 382 nm and emission at 
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470 nm (gain=10). MT content was expressed as μg MT/mg proteins. 
2.4. Gene expression 
For gene expression analysis, total RNA was extracted from P. clarkii 
hepatopancreas (30 mg from a pulverized with nitrogen pool, 2 organ-
isms × 3 tanks per condition) using the NucleoSpin® RNA isolation kit. 
RNA concentrations and quality were verifiedusing a Bioanalyzer2100 
(Agilent) and a NanoDrop 2000c (Thermo Scientific)spectrophotometer. 
The cDNA synthesis was performed using iScriptTM cDNA synthesis kit. 
Specific primers (gadph, b-act, gpx, cat, Mnsod, gst, mt, Colα, SnAp and 
Thy, Supplementary Table S2) for real-time PCR (q-PCR) were designed 
from RNA sequences obtained from GenBank (National Center for 
Biotechnology Information, NCBI) using the software Primer3 Input 
(version 0.4.0) and oligonucleotides were obtained from Biomers® 
(Ulm, Germany). 
The qPCR amplification was conducted according to the man-
facturer’s recommended procedure (Fluorescent Quantitative Detection 
System Mastercycler ep realplex2 S, Eppendorf) using PerfeCta®SYBR® 
Green FastMix®as the detection chemistry. Parameters for q-PCR were 
as follows: initial denaturation at 95 ◦C for 10 min, followed by 40 cycles 
of 95 ◦C for 15 s (amplification), annealing at the optimal temperature 
(Supplementary Table S2) for 30 s and elongation at 72 ◦C for 30 s. All 
reactions were performed in triplicates and a melting curve was gener-
ated at the end of the run to confirm the specificity of the amplification 
products. The relative expression levels of the genes was normalized 
using b-act and gadph as reference genes by the geNorm software (VBA 
application for Microsoft excel) (Vandesompele et al., 2002). 
2.5. 1DE-proteomic analysis 
The fifteen crayfish included in each experimental condition (15 
organisms per condition: 5 organisms × 3 tanks) were randomly 
distributed in three subgroups. Equal amounts of cryo-homogenized 
hepatopancreas tissue from each subgroup were pooled and used to 
determine, in triplicate, the differences in protein abundance caused by 
the treatment. Hepatopancreas tissue (100 mg) from each pool was 
homogenized in 300 μL of Tris-HCl 20 mM, pH 7.6, containing 0,5 M 
sucrose; 0,15M KCl; 20 mM DTT, 1 mM phenylmethylsulfonyl fluoride, 
6 μM leupeptin and protease inhibitors (Sigma Protease Inhibitor 
P2714). Cellular debris was removed by three consecutive centrifuga-
tions (14,000×g, 10 min, 4 ◦C). Benzonase (500 U/mL) was added to 
each protein sample and the mixtures incubated for 30 min to eliminate 
nucleic acids. Samples were then centrifugated (100,000×g, 60 min, 
4 ◦C, OptimaTM TLX Ultracentrifuge, Beckman, rotor TLA-120.2) to 
precipitate the remaining non-peptide material. Protein concentration 
was quantified using the Bradford assay. 
Isolated proteins were 1:1 mixed with 2X Laemmli SDS-PAGE buffer 
(BioRad), loaded (80 μg/lane) in triplicate onto 12% w/v SDS-PAGE gels 
(18 cm length) and separated by 1-DE gel electrophoresis (8W per gel for 
1.5 h followed by 15 W per gel for for 5.5 h, 20 ◦C in aPROTEAN II XI 
Cell, Bio-Rad). Then, the gels were stained with SYPRO® Ruby Protein 
Gel Stain (Thermo Fisher) for 18 h in the dark and imaged in an FX 
Molecular Imager (BioRad) (532 nm excitation and 555 nm emission/ 
detection). The Band Analysis tools of ImageLab software v. 4.1 (Bio- 
Rad) were used to select and determine the background-subtracted 
density of the bands. Fluorescent images of all the 1-DE gels were 
captured with the same sensitivity, and processed under the same 
parameter values to attain accurate inter-sample comparisons. 
Bands with differential intensity among the reference and exposed 
crayfish samples were automatically excised in a ProPic station (Digilab 
Genomic Solutions). Gel slices were twice bleached (30 min, 37 ◦C) with 
200 mM ammonium bicarbonate (NH4HCO3)/40% ACN and subjected 
to three additional washing steps with 100% ACN and 25 mM 
NH4HCO3/50% ACN. Finally, they were dehydrated with 100% ACN (5 
min) and dried (4 h, room temperature, RT). 
For protein identification, the protein samples were tryptically 
digested using an Investigator ProGest Digestion Station (Genomic so-
lutions). The resulting peptides were extracted from the matrix (10 μL 
10% trifluoroacetic acid TFA, 15 min, RT) and purified with C18 ZipTip 
(Millipore) microcolumns (Pro PepII station, Digilab Genomic Solutions 
Inc.). Eluents were directly loaded onto a MALDI plate using 27 mM 
α-cyano-4-hydroxycinnamic acid in 70% ACN and 0.1% TFA as the 
matrix solution. MALDI-TOF spectra were taken on AB SCIEX 4800 
MALDI TOF/TOF™ Analyzer (Applied Biosystems) in automatic mode 
with an m/z range of 800–4000, at a 20-kV accelerating voltage. The MS 
spectra were internally calibrated using peptides obtained through 
trypsin autolysis (MH+, 842.509 and 2211.104) and resulted in mass 
errors of less than 30 ppm. Filtered precursor ions were selected for the 
MS/MS scan. 
Proteins were assigned identification by Peptide Mass Fingerprinting 
and MS/MS analysis. Mascot 2.0 search engine (Mascot Search Engine, 
Matrix Science) was used for protein identification running on GPS 
software v. 3.5 (Applied Biosystems) over UniProt Arthropods database 
(892576 sequences) in automated mode, establishing the following 
searching parameters: maximum allowed error of peptide mass of 100 
ppm; cysteine as an Scarbamidomethyl-derivative; and oxidation of 
methionine. Non-identified profiles were then searched against the NCBI 
nr database (10,997,816 sequences) without any taxonomic restriction. 
3. Data analysis 
Statistical analyses were conducted using the statistical packages R 
(R Core Team, 2017) and InStat (version 3.05, GraphPad). Statistical 
significance was established at p < 0.05. 
For bioaccumulation, biochemical and gene expression data one and 
two way ANOVA (after verification of data normality and homogeneity 
of variance by the Shapiro-Wilk and Levene test respectively) were used 
to study the effects of treatments and multiples comparisons (Tukey and 
T-test) were carried out to evaluate significant differences between 
treatments. 
Statistically significant differences in protein abundance between 
each different dose and time and the reference sample was determined 
by using a Dunnet test with the Bonferroni correction, after assessing 
that the samples passed the Kolmogorov and Smirnov and Bartlett 
normality tests. 
Data for pharmaceutical accumulation in the hepatopancreas were 
used to calculate the bioconcentration factor (BCF) as ratio between the 
analyte concentration in the tissue and in the exposure water (Arnot and 
Gobas, 2006). 
The integrated biomarker response index (IBR) was used to obtain an 
integrated view of the changes produced by pharmaceutical mixtures on 
biochemical responses. IBR values for biochemical biomarkers and gene 
expression were calculated at different time intervals according to the 
method proposed by Beliaeff and Burgeot (2002) and modified by Devin 
et al. (2014). The calculations wereperformed using Excel and R soft-
ware (Trombini et al., 2016). 
PCA was applied (PCA, XLSTAT v. 2015.2.02, Addinsoft) to bio-
markers, gene expression and proteomic data to evaluate the association 
between the different variables and the variance of each time set in 
exposed and unexposed organisms. 
4. Results 
4.1. Pharmaceuticals in exposure water and hepatopancreas 
Test solutions were renewed every 48 h and were analyzed at regular 
intervals to compare the nominal versus measured concentrations. The 
concentrations of FLU, CIP and IBU measured during the exposure phase 
after addition of stock solution were in good agreement with nominal 
concentrations (Supplementary Table S3). Measured concentrations of 
pharmaceuticals decreased between 12 and 30% after 48 h renewal of 
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test solutions. All pharmaceuticals were detected in the exposure me-
dium also during the depuration phase (water samples collected 72 h 
after starting depuration, Supplementary Table S3) indicating the exis-
tence of excretion and depuration processes that occur in the organisms 
during this phase. Pharmaceuticals were not detected in control water 
samples. 
The bioaccumulation of drugs in the hepatopancreas along the entire 
experiment is showed in Fig. 1 (data from pharmaceutical quantification 
are showed in Supplementary Table S4). No pharmaceuticals were 
detected both in crayfish from acclimatization tanks and control or-
ganisms. The BCF values were reported for each compound and con-
centration at the end of the exposure phase (day 21, BCF21). A 
progressive accumulation of all pharmaceuticals during exposure phase 
(Fig. 1) at both exposure levels was observed. 
In crayfish exposed to the mixture at 10 μg/L, levels of FLU, CIP and 
IBU in the hepatopancreas at the end of exposure were approximately 
twice as much as recorded at day 1 and FLU was the most accumulated 
compound (BCF21=2.33 L/kg for FLU versus 1.44 and 1.47 L/kg for CIP 
and IBU respectively, Fig. 1). After the depuration phase a decrease in 
the level of accumulated drugs was observed and the variation was 
dependent on the compound (41, 20 and 31% for FLU, CIP and IBU 
respectively). In the case of organisms exposed to the highest concen-
tration (100 μg/L) tissue accumulation was similar for all pharmaceu-
ticals as indicated by similar BCF21 values (1.77, 1.66 and 178 L/kg 
respectively for FLU, CIP and IBU, Fig. 1). After 7 days of depuration a 
considerable decrease of bioaccumulated drugs compared to the end of 
exposure phase was observed (47, 48 and 50% respectively for FLU, CIP 
and IBU). 
4.2. Biochemical responses 
Pharmaceuticals altered the biochemical biomarkers in the hepato-
pancreas. Exposure to the mixture at 10 μg/L induced significant in-
crease (p < 0.05) of SOD activity after 1 and 21 days of exposure (Fig. 2) 
compared to the control while no significant changes were observed for 
the rest of biomarkers. More changes were observed in hepatopancreas 
of organisms exposed to the highest dose of pharmaceutical mixture 
(Fig. 2) with significant (p < 0.05) increase of SOD (day 21), CAT (day 
7), T-GPx (day 7), and GST (days 7 and 21) activities and decrease of GR 
activity and LPO level (day 21). This is also confirmed by PCA results 
(Fig. 4A) concerning the exposure period: SOD, GST, T-GPx and LPO 
have strong correlation (0.79, 0.98, 0.81 and − 0.78 respectively) with 
the first dimension F1 (that explains 47.18% of the total variance) and 
are positively associated (except LPO that shows negative association) 
with the lowest mixture concentration at day 7 and with both treatments 
at day 21. PCA dimension 2 explains18.59% of the total variance and 
strong correlation was observed with GR (0.79), negatively associated 
with the highest mixture concentration at day 21. After 7 days of dep-
uration, enzyme activities and LPO levels in organisms pre-exposed to 
the pharmaceutical mixtures were similar to the control with the 
exception of GR (significant higher activity in organisms pre-exposed to 
the mixture at 100 μg/L compared to the control, p < 0.05) and GST 
(significant lower activity in exposure to the mixture at 10 μg/L with 
respect to the control, p < 0.05). No changes were observed in AChE 
activity and MT levels at the two exposure doses and both in the expo-
sure and depuration phase (Fig. 2). 
Biochemical responses have been treated jointly to obtain the nu-
merical index IBR, reflecting an overview of the changes produced by 
exposure to pharmaceutical mixtures. In Table 1, IBR values at different 
exposure times and conditions are reported. IBR values increased during 
the first week of exposure (days 1 and 7) in organisms exposed to the 
pharmaceutical mixture compared to the control and this increase was 
greater at higher exposure dose. At the end of exposure phase (day 21) 
similar IBR values were obtained for both control and exposed organ-
isms. After depuration phase (day 28) the IBR values obtained for con-
trol and organisms exposed to the highest exposure concentration of 
drug mixture were similar (and lower compared to IBR values obtained 
for the day 21). On the other hand, the IBR value for organisms exposed 
to the mixture at 10 μg/L was higher with respect to the control and 
similar to the value obtained at the end of exposure phase. 
4.3. Gene expression 
Temporal evolution of selected genes is shown in the Fig. 3. Mnsod, 
gpx, gst, Thy and Colα mRNA expression was significantly (p < 0.05) up- 
regulated after 7 days in hepatopancreas of crayfishes exposed to the 
mixture at 10 μg/L. Significant changes in gene expression after the first 
exposure week at the lowest mixture concentration is also confirmed by 
Fig. 1. Flumequine (FLU), ciprofloxacin (CIP) and ibuprofen (IBU) concentrations (ng/g wet weight) (mean ± standard deviation, n=3) in the hepatopancreas of 
Procambarus clarkii exposed to pharmaceutical mixture at 10 (A) and 100 (B) μg/L. For each compound, letters indicate statistically significant differences (p < 0.05) 
between different exposure times. Numbers represent the bioconcentration factor (L/Kg) corresponding to each compound at the end of the exposure phase (day 
21, BCF21). 
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the principal component analysis (Fig. 4B) that shows strong correlation 
between Mnsod, gpx, gst, Thy, Colα, cat and SnAp (0.74, 0.70, 0.83, 0.86, 
0.78, 0.86 and 0.78 respectively) and the first dimension F1 (that ex-
plains 57.24% of the total variance), and positive association of these 
genes in crayfish exposed to 10 μg/Lat day 7.Expression levels for these 
genes were recovered at the end of exposure phase (day 21, no differ-
ences between control and exposed were observed). For the other genes 
no significant differences were observed with respect to the control 
throughout the exposure period. Similarly, at the end of depuration 
phase the expression levels of all genes under study did not show sig-
nificant differences between control and organisms pre-exposed to the 
pharmaceutical mixtures. 
Fig. 2. Biochemical biomarkers in the hepatopancreas of Procambarus clarkii exposed to the pharmaceutical mixture at 10 and 100 μg/L. Values represent the mean 
± standard deviation for n=3 replicates of pooled samples. Asterisks indicate significant differences (p < 0.05) from the control. Solid and dashed lines represent the 
value (mean ± standard deviation) for each biomarker at the day 0 (from the depuration tank). 
Table 1 
Integrated Biomarker Responses (IBR) values for biochemical responses in 
hepatopancreas of Procambarus clarkii at different experimental conditions 
(control and mixture at 10 and 100 μg/L) and exposure times (1, 7, 21 and 28 
days). Asterisks indicate IBR values for control at the day 0 (organisms from the 
depuration tank).  
Experimental condition Exposure time 
0d 1d 7d 21d 28d 
Control 1.68* 5.49 5.63 11.47 7.69 
10 μg/L  9.94 10.42 12.24 13.77 
100 μg/L  16.26 17.23 15.18 6.62  
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4.4. Proteomic 
For each experimental condition, three biological replicates (each 
composed by proteins coming from 5 animals) were loaded. A total of 44 
bands evenly distributed across the Mw range were resolved in the gels 
(two representative gels used to determine changes in the protein 
abundance profiles caused by exposure to the drug cocktail in the 
samples collected after different time and doses are shown in Supple-
mentary Fig. S5). Twenty-nine bands showed statistically significant 
changes in abundance (p < 0.05). In order to better understand the 
meaning of these differences, an analysis of principal components was 
applied to the data considering doses, times and intensity of the bands. 
The results are shown in Fig. 4C. The PCA analysis separated the control 
and the exposed animals and differentiated the groups corresponding to 
animals treated with each of the tested doses (0,10 μg/L and 100 μg/L). 
The first two components explained >60% of the total variation. PC1 
(39%) separated control from drug cocktail exposed crayfish, and PC2 
(26.3%) separated both exposure groups, pointing to the dose of 10 μg/L 
as the most effective. 
Bands of interest were split and analyzed by MALDI-TOF-TOF for 
identification. Twenty-five protein bands were identified, corresponding 
to 22 different protein species (two bands were identified as GST and 
three others as ACT) (Table 2). Seven of the protein sequences obtained 
correspond to proteins of unknown function. Thirteen differentially 
expressed proteins increased their abundance with treatment as a 
function of dose and time of exposure. These include haemocyanin (HC, 
Fig. 3. Relative gene expression in hepatopancreas of Procambarus clarkii exposed to pharmaceutical mixture at 10 and 100 μg/L. Values represent mean ± standard 
deviation for n=3 replicates of pooled samples. Asterisks indicate significant differences (p < 0.05) from the control. 
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bands 5 and 6); catalase (CAT, band 9); actin (ACT, bands 15, 23 and 
24); glyceraldehyde 3-P dehydrogenase (GAPDH, band 22); superoxide 
dismutase (SOD, band 25); glutathione S-transferase (GST, bands 29 and 
38); dihydroxy acid dehydrate (DHAD, band 32) and alkaline phos-
phatase (ALP, band 34). In contrast, immunoglobulin alpha-1 (IGHA1, 
band 19) and ferritin (FER, band 37) decreased their amount depending 
on the intensity of the treatment. The remaining proteins increased their 
levels at the dose of 10 μg/L but showed an irregular behavior at the 
higher tested dose. These results demonstrate that the drugs are being 
incorporated by P. clarkii and that even the environmentally relevant 
dose of 10 μg/L alters the proteostasis in the crayfish hepatopancreas 
and hence disturbs the animal’s metabolism, as will be discussed later. 
5. Discussion 
The crayfish P. clarkii is considered as a good model organism for the 
evaluation of alterations produced by pollutants through in vivo labo-
ratory assays (Antón et al., 2000). Ecotoxicological studies carried out to 
date focus mainly on the effects produced on this organism by metals 
and pesticides (Gago-Tinoco et al., 2014; Suárez-Serrano et al., 2010; 
Vioque-Fernández et al., 2009b; Zhao et al., 2019 among others) 
whereas the impact of pharmaceutical exposure is poorly investigated 
and most of works focus on psychoactive drugs (antiepileptics, anxio-
lytics, anaesthetics, etc.) and their effects on neurotransmission, move-
ment and behaviour in P. clarkii (Cooper et al., 2001; Hossain et al., 
2021; Majeed et al., 2015; Sewell et al., 1984 among others). 
In this study, the selected pharmaceuticals accumulated progres-
sively in the hepatopancreas throughout the exposure period. Uptake 
and bioconcentration of pharmaceuticals by aquatic organisms are 
mostly dependant on physico-chemical characteristics of exposure me-
dium and properties of selected contaminant molecules. The octanol/ 
water partition coefficient (logKow) can be used to predict the accumu-
lation potential of pollutants by calculating a theoretical bio-
concentration factor (BCF). According to the BCF values found in the 
existing literature, IBU, CIP and FLU (logKow-based BCF=3 L/kg for all 
compounds) are considered to have a low tendency to bioconcentrate in 
aquatic organisms (Franke et al., 1994; http://toxnet.nlm.nih.gov). BCF 
values obtained in this work for the hepatopancreas of P. clarkii at the 
end of exposure phase varied between 1.44 and 2.33 L/kg proving the 
very low accumulation potential for the three pharmaceuticals. Addi-
tionally, a theoretical accumulation order can be derived by logKow 
values (IBU > FLU > CIP, according to the criteria that accumulation 
and logKow are linearly related), or pKa (FLU > CIP > IBU, non-ionized 
molecules accumulate more easily than ionic forms and, at pH values 
typical of surface waters, molecular ionization increases with decreasing 
pKa) (Supplementary Table S1) (Barron, 1990; Daughton and Brooks, 
2011). Results obtained in the assay with P. clarkii did not agree with 
theoretical predictions (with exception of FLU whose higher accumu-
lation could be related to the greater abundance of non-ionized form in 
the aquatic medium). Besides physico-chemical properties of the expo-
sure medium and selected chemicals, the biological characteristics of 
exposed organisms and contaminant dose and composition affect ab-
sorption and accumulation of pharmaceuticals (Arnot and Gobas, 2006; 
Barron, 1990; Ding et al., 2017; Smith et al., 2010). 
Pharmaceutical accumulation in the hepatopancreas of P. clarkii 
showed to change depending on compound and exposure dose. BCF 
values obtained at day 21 indicate a higher accumulation of FLU in 
hepatopancreas of organisms exposed to mixture at 10 μg/L. Similar 
results were observed in molluscs (Dreissena polymorpha exposed to CBZ 
and IBU) and fish (Onchorhynchus mykiss exposed to IBU) that after 
exposure to increasing concentrations of pharmaceuticals exhibited 
higher BCF values at lower concentrations (Brown et al., 2007; Con-
tardo-Jara et al., 2011). Additionally, a variation of accumulation 
pattern over time was observed at both exposure doses: the accumula-
tion rate at 100 μg/L was continuous throughout exposure time whereas 
at 10 μg/L a different behavior for the three compounds was observed. 
Low or no-accumulation rate (as observed at 10 μg/L for CIP from day 
1–21 or for IBU from day 1–7) may be due to metabolic and detoxifi-
cation processes that counterbalance uptake of pharmaceuticals so that 
accumulation does not occur (Almeida et al., 2017; Garcia et al., 2012). 
Fig. 4. PCA graphs based on biomarker responses (A), gene expression level (B) and protein abundance (C) in hepatopancreas of Procambarus clarkii during the 
exposure phase. The control (c) and pharmaceutical mixture concentrations (10 and 100 μg/L) are indicated for each sampling day (0, 1, 7 and 21 d). 




Identification of proteins differentially expressed in the digestive gland of Procambarus clarkii exposed to a mixture of ibuprofen, flumequine and ciprofloxacin during different times. Asterisks indicate statistically 
significant changes in protein expression compared to the control.  
Band 
number 

















Fragmented ions Ion 
score 
Protein symbol Fold change (dose vs control) 
10 μg/L 100 μg/L 
Day 1 Day 7 Day 21 Day 1 Day 7 Day 21 
1 Hexokinase tr|F6JFS6| 
F6JFS 
28.11 78.36 5.03 58 5 100 – – HEXA − 1.48* 1.08 3.46* − 1.16 1.80* − 1.04 
5 Hemocyanin B chain sp|P83180| 
HCYB_ 
65.53 66.00 5.81 190 12 27 LLEQHHWFSLFNTR 52 HC 1.18 1.49* 1.40 1.09 1.01 1.07 
DSYGYHLDR 41 
YGGEFPARPDNVHFEDVDGVAR 30 
6 Hemocyanin B chain sp|P83180| 
HCYB_ 
65.53 64.66 5.81 126 10 24 LLEQHHWFSLFNTR 76 HC 1.76* 2.57* 2.54* 3.20* 2.99* 3.04* 
9 Catalase tr|B2XQY0| 
B2XQY 





gi|224532894 254.47 52.01 4.74 101 31 16 – – CHP 1.44 1.18 1.00 − 6.72* 6.56* 24.92* 
11 3-hydroxyacyl-CoA 
dehydrogenase 
gi|239995542 77.34 50.66 7.54 103 19 28 – – HADH 1.00 1.09 − 1.30 − 2.59* 3.33* 7.74* 
12 Alkanesulfonate 
monooxygenase 
gi|254562587 42.68 49.87 5.9 80 12 35 – – SSUD 1.00 1.34 − 1.38 − 1.13 1.29 − 1.59* 




306.75 47.23 4.94 88 30 15 – – G6CNE4 1.00 − 1.04 − 2.09* 2.81* 2.94* 3.62* 
15 Actin gi|156773 
/AAA28321.1 
42.15 44.29 5.22 175 8 29 AVFPSIVGRPR 10 ACTB 1.15 1.68* 1.00 1.19 1.75* − 1.26 
VAPEEHPVLLTEAPLNPK 83 
QEYDESGPSIVHR 35 




15.24 40.85 9.13 89 6 40 STDYGIFQINSR 48 LYZ − 1.71* − 3.27* − 1.04 7.92* 12.19* 22.80* 
19 Immunoglobulin 




54.65 39.14 6.49 91 5 18 WLQGSQELPR 33 IGHA1 − 1.25 1.30 1.05 − 1.40 − 1.91* − 37.65* 
QEPSQGTTTFAVTSILR 37 










35.97 35.20 6.54 242 9 41 IGINGFGR 18 GAPDH − 1.11 1.11 − 1.01 4.87* 6.94* − 1.86* 
VPTPDVSVVDLTVR 97 
VVSWYDNEFGYSTR 67 




42.06 33.76 5.3 195 8 29 VAPEEHPVLLTEAPLNPK 97 ACTB 1.10 1.33 1.10 2.92* 3.43* 2.31* 
GYTFTTTAER 30 
SYELPDGQVITIGNER 21 
24 Gamma actin (partial) gi|21541270/ 
CAD10659.1 
17.31 31.00 5.06 126 5 44 VAPEEHPVLLTEAPINPK 60 ACTB 1.10 1.05 1.10 1.88* 2.56* 2.66* 
GYTFTTTAER 28 




31.51 30.46 5.44 95 8 29 AFFNVINWSNVNER 42 MnSOD 1.19 1.47* 3.02* 1.13 1.49* 2.44* 
26 Leucyl-tRNA 
synthetase 
gi|37679095 97.20 29.49 4.95 105 19 23 – – LARS 1.26 − 1.43 − 1.81* 1.47* 2.28* 128.46* 




25.43 23.55 4.97 92 9 37 SYAEYVYR 31 GST 1.25 1.33 1.26 1.20 1.55* 1.91* 
30 PREDICTED: nuclear 
mitotic apparatus 
protein 1 
gi|119907521 238.56 23.37 5.49 79 25 15 – – NMAP1 1.09 1.00 1.00 1.02 1.29 1.11 
32 Dihydroxy-acid 
dehydratase 
gi|186473830 66.94 21.94 5.73 84 14 27 ITPGMLMAAMR 3 DHAD 11.52* − 1.32 1.09 1.97* − 1.04 − 15.17* 
34 Alkaline phosphatase gi|161727372/ 
BAF94313.1 
12.30 21.28 10.01 82 9 70 – – ALP 2.13* 2.75* 4.07* 15.30* 17.23* 23.45* 
(continued on next page) 
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Furthermore, we can suppose that high exposure levels cause an 
imbalance between the accumulation and elimination processes, pro-
ducing a progressive accumulation of drugs along the time. 
The decrease in the level of pharmaceuticals accumulated in hepa-
topancreas after 7 days of depuration indicates the ability of P. clarkii to 
carry out regulatory processes (metabolization and excretion) that 
allow eliminating these compounds and the existence of these processes 
is confirmed by the presence of IBU, CIP and FLU in the water at the end 
of the depuration phase (Almeida et al., 2017). 
It is well known that the presence of low levels of pollutants in the 
aquatic medium as well as their low bioaccumulation is not indicative 
of the absence of ecotoxicological risk for organisms. Most pharma-
ceuticals have shown to induce adverse effects in aquatic organisms at 
very low concentrations (ng-μg/L) (Almeida et al., 2020; Fabbri and 
Franzellitti, 2015; Parolini, 2020, among others). 
Proteomic methods evaluate modifications in protein abundance 
profiles that can be used as biomarkers of contamination while 
providing data on the toxicity mechanisms of contaminants. The 
selected approach (1-DE SDS-PAGE) allowed us to have a global vision 
of the hepatopancreas proteome of P. clarkii exposed to different doses 
of the mixture. The hepatopancreas is a multifunctional and vital organ 
for crustaceans with a key role in metabolic processes, nutrient uptake 
and immune functions (Roszer, 2014). Additionally it is considered a 
target organ for many environmental stressors and is involved in 
accumulation and detoxification processes (Zhang et al., 2019).The 
proteomic analysis identified 22 different proteins whose abundance 
changed in the hepatopancreas after the pharmaceutical cocktail 
exposure, depending on time and/or dose. The functional analysis of the 
differentially expressed proteins showed alterations in main cell func-
tions: biotransformation and detoxification of xenobiotics, cytoskeleton 
homeostasis, carbohydrate metabolism and immune response. As dis-
cussed below, the alteration of these specific groups of proteins is 
probably linked to the ability of IBU, FLU and CIP to generate reactive 
oxygen species (ROS) in the cell and the subsequent onset of an anti-
oxidant response (Bartoskova et al., 2013; Gonzalez-Rey and Bebianno, 
2011; Kashida et al., 2006; Nunes et al., 2018; Zivna et al., 2015). Some 
of the proteins identified in this untargeted proteomic approach form 
part of the classical biomarkers battery that we choose to perform in this 
work, confirming the adequacy of our selection. 
In the category of biotransformation and detoxification of xenobi-
otics 5 proteins (23%) are included: CAT (band 9), SOD (band 25) and 
GST (bands 29) increased their concentration, while SSUD (band 12) 
and UBS (band 43) diminished in abundance in treated crayfish. These 
alterations were particularly relevant at the highest exposure dose. 
Glutathione S-transferases (GSTs) are essential Phase-II detoxifica-
tion enzymes, which catalyze the conjugation of a variety of endoge-
nous/exogenous compounds with reduced glutathione (GSH) for their 
excretion (Hayes and Strange, 2000). Two bands, 29 and 38 (Table 2) 
were identified as Glutathione S-transferase D1 in our study. However, 
the Mw of band 38 suggests that it corresponds to a fragment of the 
original protein and then, changes in its concentration probably do not 
reflect variations in its associated function. Both the amount of GST 
protein and its activity (Table 2, band 29 and Fig. 2) increased with the 
concentration of the drug cocktail and the exposure time. Increased 
activity of GST has been described in Carcinus maenas, Ruditapes phil-
ippinarum and zebrafish Danio rerio exposed to IBU (Aguirre-Martinez 
et al. 2013, 2016, 2016; Bartoskova et al., 2013). GST activation has 
been also associated with FLU and CIP exposures (Kashida et al., 2006; 
Nunes et al., 2018), evidencing that the metabolism of the selected 
drugs requires the activation of the glutathione conjugation pathway. 
Cells are protected against ROS generated by pollutants through a 
battery of enzymes such as CAT, SOD or GPxs (Bartoskova et al., 2013; 
Gonzalez-Rey and Bebianno, 2011; Kashida et al., 2006; Nunes et al., 
2018; Zivna et al., 2015). The combined proteomic approach and the 
study of enzyme activities showed increased amounts and activity of 
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of treated P. clarkii (Table 2 and Fig. 2), as expected from their respective 
roles in the cells: to detoxify peroxides and anion superoxide. For GST, 
CAT, SOD and GPx, alterations were also observed at transcriptional 
level: all genes encoding for these enzymes were over-expressed after 7 
d of exposure at the mixture at 10 μg/L (Fig. 3). An enhanced tran-
scription of CAT and SOD was also observed in the digestive gland of 
D. polymorpha exposed to low IBU concentrations (20 and 200 μg IBU/L 
after 1 day for CAT, 0.2 and 2 μg IBU/L after 4 days for SOD) (Con-
tardo-Jara et al., 2011). Moreover, IBU exposure induced up-regulation 
of GST genes in Daphnia magna (5 and 50 μg/L) and Crassostrea gigas (1 
and 100 μg/L); in oyster, similarly to our study, the most important 
changes were observed at the lowest exposure concentration and the 
authors suggested the induction of a hormesis-like effect with a low-dose 
transcriptional stimulation and high-dose inhibition to explain the gene 
expression trend (Serrano et al., 2015; Wang et al., 2016). Milan and 
coauthors (2013) analyzed the transcriptomic responses to IBU (100 and 
1000 μg/L) in R. philippinarum and observed up-regulation of a number 
of genes involved in xenobiotic metabolism, including different forms of 
GST. Disruption of pathways associated with glutathione and xenobi-
otics metabolism as a consequence of down regulation of various GSTs 
genes was observed by Pomati et al. (2007) in zebrafish liver cells 
exposed to a pharmaceutical cocktail including IBU and CIP at envi-
ronmentally relevant concentrations. It should be noted that changes in 
protein abundance, mRNA transcript levels and enzyme activity in GST, 
CAT and SOD are not parallel under all circumstances. Antioxidant de-
fense responses can be regulated at different levels, transcriptional, 
translational, and post-translational, and these alterations can occur at 
the same time or independently of each other, depending on the 
pollutant, dose and time of exposure, generating different patterns of 
gene transcription levels, protein abundance and enzyme activities 
(Defo et al., 2015; Regoli et al., 2011; Zheng et al., 2016a, b). Increased 
levels of gene expression without post-transcriptional changes under 
low contamination conditions can represents a pre-adaptation mecha-
nism through which, if the contaminant concentration increases or ex-
tends over time, organisms would be prepared to increase the activity of 
antioxidant defenses when they need it (Pillet et al., 2019). This 
mechanism could be related to the cellular content of ROS; we can hy-
pothesize that, under low contamination conditions, the intracellular 
ROS level (produced in normal metabolic pathways such as processes 
involved in the control of pollutant accumulation and excretion) may 
increases reaching levels which are not high enough to produce oxida-
tive stress (and consequently activation of antioxidant defense system) 
but sufficient to induce transcriptional factors that regulate the expres-
sion of different genes. 
The detoxification and antioxidant mechanisms activated in the 
crayfish hepatopancreas appear to be effective in controlling the ROS 
internal content and prevent oxidative damage, as indicated by low LPO 
levels (similar or even lower with respect to the control, Fig. 2) 
throughout the entire exposure phase at both exposure doses. IBU in-
duces alterations in enzymatic activity and possible oxidative damage in 
the digestive gland/hepatopancreas of different freshwater (Corbicula 
fluminea) and marine (R. philippinarum and C. maenas) organisms 
exposed to 50 μg IBU/L during a period similar to this study (Aguirre--
Martínez et al. 2013, 2015, 2016, 2018). CIP showed to induce alter-
ations in the antioxidant system of microalgae Pseudokirchneriella 
subcapitata and Chlamyidomonas mexicana (induction of CAT, SOD and 
GPx activities), and in the aquatic plant Lemna minor (CAT induction) 
when present at concentrations in the order of mg/L (Gomes et al., 2017; 
Nie et al., 2013; Xiong et al., 2017). Additionally, Gust et al. (2012) 
recorded increased ROS levels in the haemocytes of the bivalve Elliptio 
complanata exposed to 2500 ng CIP/L. In the existing literature no data 
were found about the induction of oxidative stress by FLU in aquatic 
organisms. However, this compound is able of generating ROS through 
its metabolic pathways and consequently induces oxidative stress in 
hepatic mice cells (Kenmochi, 2007). 
Proteins are a target of oxidation and ROS can modify them and 
modulate both gene expression and proteins abundance (Deavall et al., 
2012; Lushchak, 2011). In the pathogenesis of liver injury (hepatic 
fibrosis, often related to oxidative stress) in mammalian, a critical step is 
the activation of stellate cells associated to increased levels of collagen 
(type I and III) (Lee et al. 1995, 2001, 2001; Li et al., 2016; Shi and 
Rockey, 2017). According to these information, we can speculate that 
the increase in collagen expression observed in this study could be 
related to an initial inflammatory process in the hepatopancreas tissues 
induced by pharmaceutical exposure. We found here increased levels of 
HEXA and GAPDH, two enzymes involved in carbohydrate metabolism. 
HEXA is the enzyme responsible for the phosphorylation of glucose to 
glucose 6-phosphate and the initiation of glucose metabolism through 
both glycolysis and the pentose phosphate pathway (PPP). GAPDH ox-
idizes the triose glyceraldehyde 3-phosphate (G-3P), the product of 
glycolysis, fructose catabolism, PPP and glycerol metabolism so that 
G-3P follows its path to become pyruvate. Increased glucose metabolism 
has been detected in crustaceans such as C. maenas or Homarus ameri-
canus after pollutant exposure and has been associated to ROS clearance 
(Lorenzon et al., 2004; Wang et al., 2017). The increased HEXA activity 
observed in treated crayfish might activate the oxidative pentose 
phosphate pathway to generate NADPH and contribute to maintaining 
the GSH levels (Tang et al., 2015), affected by excess ROS generated by 
drug cocktail exposure. 
Activation of glucose metabolism in crustacean under oxidative 
stress conditions is regulated by the crustacean hyperglycemic hormone, 
CHH, and abundant neuropeptide that stimulated lipid mobilization 
from the storage tissues (e.g., the hepatopancreas) including free fatty 
acids release into haemolymph, to be used metabolically (Lorenzon 
et al., 2004; Santos et al., 1997). The levels of 3-hydroxyacyl-CoA de-
hydrogenase (HADH) resulted increased in the hepatopancreas of 
P. clarkii after the drug cocktail exposure. This enzyme is essential for 
catalyzing the penultimate reaction of β-oxidation. HADH upregulation 
might reflect alterations of the lipids signaling pathways in the control of 
insulin secretion (Prentki, 1996). 
The most intense band detected in the gels in all experimental con-
ditions (Supplementary Fig. S5) was identified as hemocyanins (HC, 
bands 5 and 6), and their levels resulted increased in the crayfish 
exposed to the pharmaceutical mixture. HCs are copper-containing 
respiratory proteins, synthesized in the hepatopancreas, with essential 
roles in innate immunity. As an invertebrate, P. clarkii has no adaptive 
immunity and HCs provide an immediate and rapid immune response to 
invading microorganisms or other stressing situations, including expo-
sure to pollutants (Hoffmann and Reichhart, 2002; Qin et al., 2018). 
Jebali and coauthors (2014) observed an induction of this protein in the 
crab C. maenas after transplantation in an area contaminated by hy-
drocarbons and metals and related it with regulation of immune system 
and oxygen transport activity. The levels of lysozyme (LYZ), one of the 
most important non-specific immune indicators, also resulted increased 
by the treatment. These results suggest that HCs and LYZ are inducible 
and up-regulated in response to this combination of drugs, confirming 
that both proteins participate in the innate immune response in P. clarkii 
(Fernández-Cisnal et al., 2014). Ferritin (FER) has a key role in iron 
homeostasis and also participates in many biological processes, 
including oxidation and immune response (Theil, 1987). Up-regulated 
expression of the ferritin mRNA has been reported in the hepatopan-
creas of crustaceans after viral infection and in crabs from polluted areas 
(urban, industrial and agricultar contamination) (Ghedira et al., 2016; 
Nayak et al., 2011; Zhang et al., 2006). However, in our study FER 
resulted increased only by low doses and short times (Table 2). In any 
other case, a substantial diminution in protein abundance was detected. 
In agreement with our results, several studies have reported the 
down-regulation of ferritin mRNA in crustaceans after exposure to 
oxidant elements like metals or pesticides (Osuna-Jiménez et al., 2014; 
Poynton et al., 2011; Taylor et al., 2013). In previous work Fernán-
dez-Cisnal et al. (2017) reported decreased FER protein levels in the 
hepatopancreas of pollution exposed P. clarkii individuals paralleled by 
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clear signs of oxidative stress and significant deregulation of proteins 
involved in the immune response. By using redox proteomics, the same 
authors proposed that the decrease in FER levels was caused by a sub-
stantial increase in the oxidation status of this protein that results in 
aggregates rapidly removed as part of the antioxidant defense strategy 
(Fernández-Cisnal et al., 2014; Welch et al., 2002). 
Overall, the results obtained in proteomic, transcriptional and 
biochemical analyses suggest that the cocktail of IBU, CIP and FLU 
generates oxidative stress in the hepatopancreas of P. clarkii. An anti-
oxidative stress response is consequently elicited that derives glucose to 
oxidative PPP, seeking to obtain the NADPH needed to maintain the 
levels of GSH used by several biotransforming (i.e., GST) and antioxi-
dant enzymes (i.e., SOD, CAT). An uneven effect was apparently exerted 
over different components of the crayfish immune response, since HC 
and LYZ increased, but other proteins such as IGHA1 and FER dimin-
ished with the dose and the time. However, at least in the case of FER, 
diminution might be consequence of its sensitivity to oxidation and 
further degradation. Down-regulation of FER by the pharmaceutical 
cocktail might potentiate their toxicity, given that FER is also considered 
as part of the antioxidant response. 
6. Conclusions 
Our study provides data about the toxicity of a mixture of cipro-
floxacin, flumequine and ibuprofen on the crayfish Procambarus clarkii 
contributing to improve the knowledge regarding the interaction be-
tween pharmaceuticals and aquatic organisms. Pharmaceuticals are 
accumulated in the hepatopancreas and, despite the low accumulation 
potential shown, induced alterations at different levels of biological 
organization. Changes in molecules related with antioxidant and 
detoxification processes, both from the point of view of gene expression, 
protein abundance and enzymatic activity indicate that an alteration of 
the redox status and the activation of mechanisms to reduce the accu-
mulated drugs occurs in the hepatopancreas of the crayfish. 
The assessment of classical biomarkers as well as the expression of 
genes, both selected a priori, is useful to detect specific alterations (i.e. 
oxidative stress or neurotoxicity) in organisms exposed to environ-
mental contaminants. On the other hand, proteomics, as large-scale 
study of proteins, provides information about the cell’s protein 
composition of a selected biological system and its variation under 
different exposure conditions, allowing us to unravel mechanisms of 
action of selected contaminants and biological processes and/or path-
ways affected by them. 
Results obtained in this study support the usefulness of evaluating 
the selected responses over time (medium or long term) to observe the 
evolution of health status of the organism (evolution of effects at 
different biological organization levels, recovery, induction of perma-
nent damage, etc.). In the case of P. clarkii we observed that it was 
capable of overcoming the alterations related to the oxidative stress and, 
after removal of pharmaceuticals from the exposure medium (depu-
ration), have a redox state similar to control organisms. 
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